EIDP, Inc. CTA-PB

Healthcare SIC 2820 - Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) NAICS Manufacturing › Chemical Manufacturing › Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing › Resin and Synthetic Rubber Manufacturing derived NYSE

Unless otherwise indicated or the context otherwise requires, references in this Annual Report on Form 10-K to:

•"Corteva" or "the company" refers to Corteva, Inc. and its consolidated subsidiaries (including EIDP);

•"EIDP" refers to EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) and its consolidated subsidiaries or EIDP, Inc. excluding its consolidated subsidiaries, as the context may indicate;

•"DowDuPont" refers to DowDuPont Inc. and its subsidiaries prior to the Corteva Separation (as defined below);

Read the full description Show less

Last close —

Market cap —

52-week range — - —

Valuation FY2018 figures against the last close

P/S—

P/E—

P/FCF—

EV/EBITDA—

Dividend yield—

Diluted EPS—

Annual financial statements

Income statement

Fiscal year	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenue	—	—	$24.59B	$25.13B	$28.41B	$29.00B	$34.81B	$33.68B	$27.70B	$26.11B
Cost of revenue	—	—	$14.47B	$15.11B	$17.02B	$17.64B	$21.40B	$21.26B	—	—
Gross profit	—	—	$10.12B	$10.02B	$11.38B	$11.36B	$13.41B	$12.42B	—	—
R&D	—	—	$1.64B	$1.90B	$1.96B	$2.04B	$2.12B	$1.96B	$1.60B	$1.38B
SG&A	—	—	$4.32B	$4.62B	$4.89B	$5.34B	$5.89B	$3.31B	$2.91B	$3.44B
Total operating expenses	—	—	—	—	$31.05B	$32.66B	$32.22B	$30.54B	$25.64B	$25.14B
Operating income	—	—	—	—	$6.36B	$5.37B	$5.37B	$5.88B	$4.61B	$3.34B
Pre-tax income	—	—	$3.27B	$2.59B	$4.31B	$2.57B	$3.09B	$3.88B	$3.26B	$2.18B
Income tax	—	—	$744.0M	$696.0M	$1.17B	$360.0M	$616.0M	$647.0M	$515.0M	$415.0M
Net income	—	—	$2.51B	$1.95B	$3.62B	$4.85B	$2.75B	$3.56B	$3.03B	$1.75B
EPS, basic	—	—	2.87	2.17	3.95	5.22	2.94	3.82	3.32	1.93
EPS, diluted	—	—	2.85	2.16	3.92	5.18	2.91	3.77	3.28	1.92
Shares, diluted (wtd. avg.)	—	—	877.0M	899.5M	921.9M	933.1M	942.2M	941.0M	921.7M	908.7M

Balance sheet

Fiscal year	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Cash and equivalents	$4.47B	$7.25B	$4.61B	$5.30B	$6.91B	$8.94B	$4.28B	$3.59B	$4.26B	$4.02B
Short-term investments	$34.0M	$952.0M	$1.36B	$906.0M	$124.0M	$145.0M	$123.0M	$433.0M	$2.54B	$2.12B
Receivables	$3.91B	$3.78B	$3.61B	$3.44B	$3.69B	$4.58B	$4.07B	$4.60B	$4.12B	$3.79B
Inventory	$7.41B	$8.63B	$5.67B	$6.14B	$6.79B	$8.04B	$7.57B	$7.20B	$5.97B	$5.38B
Total current assets	$18.61B	$23.05B	$17.12B	$17.39B	$26.08B	$24.38B	$21.32B	$18.06B	$19.06B	$17.29B
Property, plant and equipment	$12.19B	$12.44B	$9.23B	$9.78B	$10.01B	$9.95B	$12.74B	$13.41B	$11.34B	$11.09B
Goodwill	$40.69B	$45.59B	$4.18B	$4.25B	$4.33B	$4.51B	$4.62B	$5.41B	$2.62B	$2.14B
Other intangibles	$26.05B	$27.73B	$3.66B	$4.14B	$4.57B	$5.10B	$5.13B	$5.41B	$2.70B	$2.55B
Total assets	$101.03B	$112.96B	$39.96B	$41.17B	$50.49B	$52.14B	$49.86B	$48.64B	$40.41B	$38.19B
Accounts payable	$4.98B	$4.83B	$3.71B	$3.40B	$3.79B	$5.18B	$4.85B	$4.82B	$4.35B	$3.54B
Short-term debt	$268.0M	$1.31B	$4.0M	$1.11B	$1.41B	$1.67B	$1.25B	$410.0M	$4.0M	$981.0M
Total current liabilities	$11.44B	$12.14B	$8.90B	$10.32B	$13.80B	$13.37B	$13.55B	$11.19B	$9.39B	$9.39B
Long-term debt	—	—	$8.10B	$7.63B	$9.22B	$10.72B	$10.44B	$11.71B	$10.13B	$9.52B
Total liabilities	—	—	$29.77B	$30.97B	$37.11B	$35.21B	$39.56B	$39.43B	$30.67B	$30.53B
Retained earnings	-$7.67B	$175.0M	$14.92B	$14.51B	$16.89B	$16.78B	$14.38B	$13.42B	$12.03B	$10.71B
Total equity	$69.86B	$74.76B	$10.00B	$9.99B	$13.38B	$16.29B	$10.30B	$9.21B	$9.80B	$7.65B

Cash flow

Fiscal year	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Operating cash flow	—	—	$3.30B	$2.32B	$3.71B	$3.18B	$4.85B	$5.15B	$4.56B	$4.74B
Depreciation and amortisation	—	—	$1.26B	$1.47B	$1.62B	$1.60B	$1.71B	$1.56B	$1.38B	$1.50B
Capital expenditure	—	—	$1.02B	$1.63B	$2.02B	$1.88B	$1.79B	$1.84B	$1.51B	$1.31B
Investing cash flow	—	—	-$1.51B	-$1.83B	-$337.0M	$2.94B	-$1.35B	-$6.24B	-$2.44B	-$4.30B
Financing cash flow	—	—	-$2.33B	-$1.82B	-$5.07B	-$1.47B	-$2.70B	$403.0M	-$1.83B	-$97.0M
Buybacks	—	—	$916.0M	$2.35B	$2.00B	$1.00B	$400.0M	$672.0M	$250.0M	$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000030554-19-000005.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)

Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity

Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks

Revenue
Gross profit
Net income

Fiscal year	FY2009	FY2010	FY2011	FY2012	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018
Revenue	$26.11B	$27.70B	$33.68B	$34.81B	$29.00B	$28.41B	$25.13B	$24.59B	—	—
Gross profit	—	—	$12.42B	$13.41B	$11.36B	$11.38B	$10.02B	$10.12B	—	—
Net income	$1.75B	$3.03B	$3.56B	$2.75B	$4.85B	$3.62B	$1.95B	$2.51B	—	—

Recent filings and events

2026-08-31 Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
2026-08-20 Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
2026-08-20 Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
2026-08-20 Other event Item 8.01
2026-08-14 Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
2026-08-06 Regulation FD disclosure Item 7.01
2026-08-06 Other event Item 8.01
2026-02-12 Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
2025-05-14 Other event Item 8.01
2025-02-14 Annual report filed Form 10-K
2025-02-06 Accounts can no longer be relied on The company is telling investors that figures it has already published are wrong. Rare, and about as direct as a filing gets. Item 4.02
2024-02-08 Annual report filed Form 10-K

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2820

Ticker	Company	Market cap	P/E	Revenue growth
CE	Celanese Corp	$5.24B	—	-7.1%